Article
Use of CD122+ natural killer cell precursors for superior anti-leukemia responses
2022-10-24
Abstract excerpt
Acute Myeloid Leukemia (AML) is an aggressive blood cancer in adults. Intensive induction therapy successfully induces a complete response in up to 80% of the adult patients but a fraction of them is refractory or relapses. The fraction of non-responsive or relapsing patients is especially high amongst medically unfit and older patients, who cannot undergo aggressive chemotherapy treatment. Therefore, offering pat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e61eea87-8c64-5568-b6ba-d5e18a40f231
- DOI
- 10.1101/2022.10.24.513585
